Market Research Reports- Consulting Analysis Crystal Market Research Metabolomics Market

reliability of metabolic profiling of biomarkers for drug discovery and diagnosing malfunction metabolites. U.S. accounted for the major share of the North American metabolomics market in 2016, owing to factors such as easy availability of technologically advanced products, rise in adoption rate of personalized medicines, and highly developed healthcare infrastructure. Emerging markets such as China and India will exhibit favorable growth during the forecast period with rising emphasis on biopharmaceutical research and development activities in these countries. Key players in the global metabolomics market include LECO Corporation, Agilent Technologies, Inc., Waters Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Shimadzu Corporation, Human Metabolome Technologies, Inc., Metabolon, Inc. and Bruker Corporation. Product development is the key strategy adopted by the major players operating in the global market to expand and strengthen their product portfolio and increase their market share. For instance, in May 2016,Agilent Technologies Inc. introduced The Agilent 5110 ICP-OES to its lineup of inductively coupled plasma-optical emission spectrometers. This new system will facilitate more accurate ICP-OES analysis.Likewise, in November 2016, Metabolon, Inc. launched the Meta IMD test that speeds up the diagnosis of inherent metabolic disorders. Request a sample copy of Metabolomics Market Research Report @ http://www.crystalmarketresearch.com/report-sample/HC0635 Key Findings of the Research Study:     HPLC segment held the largest share of the global metabolomics market in 2016, owing to accuracy and reliability of the technique. Biomarker discovery segment held the major share of the metabolomics market in 2016, owing to the high efficiency of metabolic biomarkers for managing diseases at the metabolic level. North America held around two-fifth of the global share of the overall market in 2016, due to rise in adoption rate of personalized medicines and easy access to technologically advanced products. Asia-Pacific market is projected to grow with the highest CAGR over the forecast period as a result of rise in age related disorders and prevalence of high unmet medical needs. Inquire more about this report at: http://www.crystalmarketresearch.com/send-an- enquiry/HC0635 Metabolomics Market Segmentation By Technique:

Market Research Reports- Consulting Analysis Crystal Market Research Metabolomics Market | Página 2